ATYR FY 2021 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena

ATYRaTyr Pharma, Inc.

$93M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$1M

Operating Income

-$34M

Net Income

-$34M

EPS (Diluted)

$-1.77

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$33M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$116M

Total Liabilities

$6M

Stockholders' Equity

$109M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$10M	-100.0%
Gross Profit	-$1M	-$7M	+80.9%
Operating Income	-$34M	-$16M	-113.8%
Net Income	-$34M	-$16M	-108.1%